Baxter - 43 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. The latest closing stock price for Baxter as of April 26, 2024 is 40.13.
- The all-time high Baxter stock closing price was 87.20 on April 20, 2020.
- The Baxter 52-week high stock price is 50.21, which is 25.1% above the current share price.
- The Baxter 52-week low stock price is 31.01, which is 22.7% below the current share price.
- The average Baxter stock price for the last 52 weeks is 40.36.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 40.6723 | 38.5766 | 43.7700 | 37.6134 | 40.1300 | 4.54% |
| 2023 | 40.0108 | 49.2191 | 50.6945 | 31.2358 | 38.3879 | -21.90% |
| 2022 | 64.2905 | 82.2915 | 84.7355 | 47.9366 | 49.1516 | -39.55% |
| 2021 | 75.8737 | 74.8686 | 82.5947 | 69.3865 | 81.3158 | 8.45% |
| 2020 | 78.1301 | 79.3308 | 87.1981 | 66.2924 | 74.9807 | -2.94% |
| 2019 | 73.2445 | 59.6928 | 82.7224 | 58.9432 | 77.2522 | 28.39% |
| 2018 | 63.5285 | 60.7655 | 70.9229 | 56.1184 | 60.1682 | 2.89% |
| 2017 | 52.2250 | 39.7921 | 59.6067 | 39.7921 | 58.4767 | 47.29% |
| 2016 | 39.0743 | 32.8989 | 43.8898 | 30.7658 | 39.7025 | 17.58% |
| 2015 | 32.7375 | 34.3359 | 37.0606 | 28.4743 | 33.7663 | -1.63% |
| 2014 | 33.3414 | 31.5014 | 35.5616 | 30.2995 | 34.3265 | 8.40% |
| 2013 | 31.0886 | 29.9552 | 33.4054 | 28.8765 | 31.6653 | 7.28% |
| 2012 | 25.3105 | 21.7802 | 30.2576 | 21.3941 | 29.5168 | 38.42% |
| 2011 | 23.1152 | 21.2824 | 26.5709 | 20.3688 | 21.3234 | 0.05% |
| 2010 | 20.7044 | 23.9372 | 25.3417 | 16.7833 | 21.3119 | -11.56% |
| 2009 | 21.9384 | 22.1604 | 24.4341 | 18.8706 | 24.0974 | 11.76% |
| 2008 | 24.4994 | 22.8934 | 28.3938 | 19.4164 | 21.5610 | -6.24% |
| 2007 | 21.5465 | 18.1810 | 24.2007 | 18.1145 | 22.9964 | 26.79% |
| 2006 | 15.8159 | 14.8063 | 18.2826 | 13.6831 | 18.1380 | 24.81% |
| 2005 | 14.1877 | 13.1659 | 15.5732 | 12.6905 | 14.5323 | 10.63% |
| 2004 | 11.7752 | 11.2694 | 13.1545 | 10.7427 | 13.1355 | 15.22% |
| 2003 | 9.7503 | 10.5100 | 11.6168 | 6.7991 | 11.4001 | 11.14% |
| 2002 | 15.5032 | 19.0665 | 21.4005 | 8.6966 | 10.2572 | -46.73% |
| 2001 | 17.2028 | 15.9093 | 19.7025 | 14.4662 | 19.2568 | 22.85% |
| 2000 | 12.5524 | 10.7479 | 15.7318 | 9.0721 | 15.6750 | 42.52% |
| 1999 | 11.3417 | 10.8710 | 13.1166 | 10.1811 | 10.9983 | -0.50% |
| 1998 | 9.7524 | 8.4539 | 11.3023 | 8.2111 | 11.0534 | 29.95% |
| 1997 | 8.3791 | 6.7021 | 9.9259 | 6.7021 | 8.5062 | 25.77% |
| 1996 | 6.7431 | 6.2068 | 7.6188 | 5.9652 | 6.7631 | 8.29% |
| 1995 | 5.2234 | 4.0672 | 6.3380 | 3.9226 | 6.2455 | 51.56% |
| 1994 | 3.6189 | 3.3866 | 4.1207 | 3.0899 | 4.1207 | 21.68% |
| 1993 | 3.6644 | 4.2685 | 4.2685 | 2.7831 | 3.3866 | -21.89% |
| 1992 | 4.7549 | 5.1299 | 5.2449 | 4.0911 | 4.3355 | -17.07% |
| 1991 | 4.3752 | 3.5174 | 5.2776 | 3.2925 | 5.2279 | 45.97% |
| 1990 | 3.1212 | 3.1931 | 3.7047 | 2.5999 | 3.5816 | 14.41% |
| 1989 | 2.6569 | 2.1506 | 3.1903 | 2.1506 | 3.1305 | 45.56% |
| 1988 | 2.4915 | 2.7859 | 3.0991 | 1.9999 | 2.1506 | -20.70% |
| 1987 | 2.8752 | 2.2541 | 3.4548 | 2.1794 | 2.7120 | 18.75% |
| 1986 | 2.1532 | 1.8389 | 2.5057 | 1.8093 | 2.2838 | 22.22% |
| 1985 | 1.7332 | 1.5577 | 1.9718 | 1.4830 | 1.8686 | 19.96% |
| 1984 | 1.9337 | 2.7584 | 2.9067 | 1.4237 | 1.5577 | -43.53% |
| 1983 | 3.1739 | 2.7507 | 3.7152 | 2.5353 | 2.7584 | -3.89% |
| 1982 | 2.3012 | 2.0317 | 2.9956 | 1.8537 | 2.8699 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.430B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |